Jimenez-Cruz, J F <br/><br/>
Intravesical immunoprophylaxis in recurrent superficial bladder cancer (Stage T1): multicenter trial comparing bacille Calmette-Guérin and interferon-alpha.  [electronic resource] 

 -  Urology  Oct 1997 
 - 529-35 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0090-4295 
<br/><br/><label>Standard No.: </label>10.1016/S0090-4295(97)00303-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--administration & dosage<br/>Administration, Intravesical<br/>Adult<br/>Antineoplastic Agents--administration & dosage<br/>BCG Vaccine--administration & dosage<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--administration & dosage<br/>Male<br/>Middle Aged<br/>Neoplasm Recurrence, Local--epidemiology<br/>Neoplasm Staging<br/>Prospective Studies<br/>Recombinant Proteins<br/>Urinary Bladder Neoplasms--pathology